000225.KS · 유유제약1우
South Korea · RS rating 44 · As of 2026-10-14
| Price | 3,575.00 KRW |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 50 / 59 / 36 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 19 / 6 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +3.2% |
| Distance from 52-week high | +31.9% |
| Market cap (USD) | – |